Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis

J Neuroimmunol. 1993 Sep;47(2):115-22. doi: 10.1016/0165-5728(93)90021-p.

Abstract

HLA association with myasthenia gravis (MG) has been studied in a series of 114 patients using class I and class II genotyping after PCR amplification. Positive association was found with DR3, particularly in women (RR = 2.6) and in early MG onset (RR = 3.4). DRB1, DRB3, DQB1, DQA1 and B (B8 and B18) genotyping revealed that the association was predominantly with the B8 DRB1*03 DRB3*0101 DQB1*0201 DQA1*0501 ancestral haplotype. This haplotype frequency was also increased in patients with thymic hyperplasia (RR = 3.5) and was greatly reduced in patients with thymoma (RR = 0.35). Sixteen out of 48 patients carrying this 8.1 ancestral haplotype showed absence of B8 (n = 4) or of DR3 (n = 12). HLA class II genotyping further revealed the existence of two other significant associations. MG was positively associated with the DQB1*0604 allele (RR = 3.4), particularly in patients with thymoma (RR = 5.7). Furthermore, the disease was negatively associated with DR1 in females (RR = 0.32). These data suggest that MG is placed under the control of at least three distinct genes: (1) a class II predisposing gene in the 8.1 ancestral haplotype; (2) a thymoma-associated class II allele on the DQB1*0604 haplotype; and (3) a protective allele DR1.

MeSH terms

  • Age Factors
  • Autoantibodies / analysis
  • Base Sequence
  • Female
  • Gene Frequency
  • Genes, MHC Class II*
  • Humans
  • Male
  • Molecular Sequence Data
  • Myasthenia Gravis / classification
  • Myasthenia Gravis / genetics*
  • Myasthenia Gravis / immunology
  • Oligodeoxyribonucleotides / chemistry
  • Receptors, Nicotinic / immunology
  • Thymus Gland / pathology
  • White People

Substances

  • Autoantibodies
  • Oligodeoxyribonucleotides
  • Receptors, Nicotinic